GoodRx Holdings, Inc. (GDRX) Quality Score
Growth is the primary weakness (avg 35/100). Valuation is the relative bright spot.
Broad-market heuristics · Not a buy/sell signal
Valuation
Growth
Above 30x, priced for sustained outperformance
Under 20x cash flow, well covered
Below 2%, essentially flat
5–10% CAGR, steady but not exceptional
Business Quality & Capital Allocation
Shrinking >2%, active buybacks
Expanded 3+pp, strong improvement
Net debt/FCF of 1.2x, somewhat elevated
Below 8%, may not cover cost of capital
GoodRx Holdings (GDRX) quality: score, margins and returns
GoodRx Holdings (GDRX) scores 59/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 8 metrics each scored 0 to 100, on 9.5% operating margins and 4.3% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.
Frequently asked
Is GoodRx Holdings (GDRX) a high-quality business?+
GoodRx Holdings scores 59 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a 9.5% operating margin and a 4.3% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.
What does GoodRx Holdings's quality score measure?+
Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from GDRX's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where GoodRx Holdings scores well and where it falls behind.
What is GoodRx Holdings's return on invested capital (ROIC)?+
GoodRx Holdings earns about 4.3% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to GDRX's margins and growth on this scorecard to judge durability.
How profitable is GoodRx Holdings?+
GoodRx Holdings runs an operating margin of about 9.5% and a net margin of about 2.1%. Revenue has grown at roughly 7.7% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.
SourceQuality score computed from the 10-Q filed 5 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 8 Aug 2026. How this is calculated.
Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.
Related stocks: Services-Computer Processing & Data Preparation
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.